Results 91 to 100 of about 8,083 (126)

TSLP pretreatment inhibits M1 macrophage polarization and attenuates LPS-induced iNKT cell-dependent acute lung injury. [PDF]

Front Immunol
Zhou T, Zhang Z, Zhan Y, Wang M, Wu M, Weng X, Xu Y.   +6 more
europepmc   +1 more source

Reply to Yasuma et al.: Inhibiting iNKT Cell Activation: A Promising Strategy Against Pulmonary Fibrosis. [PDF]

Am J Respir Crit Care Med
Byrne AJ, Kumar V, Agro A, Hertz M.
europepmc   +1 more source

Repeated α-GalCer Administration Induces a Type 2 Cytokine-Biased iNKT Cell Response and Exacerbates Atopic Skin Inflammation in Vα14^Tg NC/Nga Mice. [PDF]

Biomedicines, 2021
Park HJ, Kim TC, Park YH, Lee SW, Jeon J, Park SH, Van Kaer L, Hong S.   +7 more
europepmc   +1 more source

Kidins220 and Aiolos promote thymic iNKT cell development by reducing TCR signals. [PDF]

Sci Adv
Herr LA, Fiala GJ, Sagar, Schaffer AM, Hummel JF, Zintchenko M, Raute K, Velasco Cárdenas RM, Heizmann B, Ebert K, Fehrenbach K, Janowska I, Chan S, Tanriver Y, Minguet S, Schamel WW.   +15 more
europepmc   +1 more source

The iNKT cell ligand α-GalCer prevents murine septic shock by inducing IL10-producing iNKT and B cells. [PDF]

Front Immunol
Park YH, Lee SW, Kim TC, Park HJ, Van Kaer L, Hong S.   +5 more
europepmc   +1 more source

Cytokine Output of Adipocyte-iNKT Cell Interplay Is Skewed by a Lipid-Rich Microenvironment. [PDF]

Front Endocrinol (Lausanne), 2020
van Eijkeren RJ, Morris I, Borgman A, Markovska A, Kalkhoven E.   +4 more
europepmc   +1 more source

Gpx4 Regulates Invariant NKT Cell Homeostasis and Function by Preventing Lipid Peroxidation and Ferroptosis. [PDF]

J Immunol
Sok SPM, Pipkin K, Popescu NI, Reidy M, Li B, Van Remmen H, Kinter M, Sun XH, Fan Z, Zhao M.   +9 more
europepmc   +1 more source

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.

Blood
Ren H, Elliott N, Lye B, Sharif Shohan MU, Cross JW, Field L, Ponnusamy K, Rice S, Jackson T, Leontari I, El Ouazzani N, Thomas R, Inglott S, Bartram J, Smith O, Bond J, Roberts IAG, Halsey C, Bashford-Rogers R, Milne TA, Roy A, Karadimitris A.   +21 more
europepmc   +1 more source

Human CD4⁺ iNKT cell adoptive immunotherapy induces anti-tumour responses against CD1d-negative EBV-driven B lymphoma. [PDF]

Immunology
Baiu DC, Sharma A, Schehr JL, Basu J, Smith KA, Ohashi M, Johannsen EC, Kenney SC, Gumperz JE.   +8 more
europepmc   +1 more source

Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses. [PDF]

Front Immunol, 2020
Stolk DA, de Haas A, Vree J, Duinkerken S, Lübbers J, van de Ven R, Ambrosini M, Kalay H, Bruijns S, van der Vliet HJ, de Gruijl TD, van Kooyk Y.   +11 more
europepmc   +1 more source